MAPK3 and renal cell carcinoma: As Erk signaling plays a role in RCC oncogenesis13,32–34, we examinedp-Erk1/2 at Thr202/Tyr204, finding that it was unchanged followingSC66 (3 μM, 2 h) treatment in 786-O and primary RCC cells (Fig. 3f).